Ipca Laboratories receives VAI classification from the USFDA

Ipca Laboratories stated that the US Food and Drug Administration (USFDA) has given its Piparia (Silvassa) production facility a voluntary action indicated (VAI) classification.

 

"This classification means that the facility was found to be adhering to a minimally acceptable state of compliance with regards to current good manufacturing practice," the company said.

 

According to USFDA, VAI means objectionable conditions or practices were found but the agency (here, USFDA) is not prepared to take or recommend any administrative or regulatory action. This is considered to be the second-best classification after ‘no action indicated’ and before ‘official action indicated.’

 

Ipca Laboratories is in the pharmaceutical production sector. The company specializes in the manufacture of generic APIs and formulations, primarily for the therapeutic market.

 

Source: Media Reports

Top stories
Budget

Impact of Budget on Common Man

9 mins read . 23 Jul 2024 . 12:22 PM

Budget

Finance Minister Nirmala Sitharaman to Presents Union Budget 2024

3 mins read . 23 Jul 2024 . 09:20 AM

Company

JSW Energy Arm Secures Major Solar and Energy Storage Projects

5 mins read . 23 Jul 2024 . 05:35 AM

Related Blogs
blog-logo

Share Market

blog-logo

8 mins read . 19 Jul 2024

Stock Market Trading Time in India

  • 38 people read
blog-logo

Share Market

blog-logo

11 mins read . 19 Jul 2024

How To Trade in T2T Stocks

  • 38 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions